GSK2850163 (S enantiomer)

CAS No. 2309519-81-9

GSK2850163 (S enantiomer)( —— )

Catalog No. M37684 CAS No. 2309519-81-9

GSK2850163 (S enantiomer) is the inactive enantiomer of GSK2850163. GSK2850163 is an novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1a).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 256 Get Quote
10MG 375 Get Quote
25MG 545 Get Quote
50MG 767 Get Quote
100MG 1008 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK2850163 (S enantiomer)
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK2850163 (S enantiomer) is the inactive enantiomer of GSK2850163. GSK2850163 is an novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1a).
  • Description
    GSK2850163 S enantiomer is the inactive enantiomer of GSK2850163. GSK2850163 is an inositol-requiring enzyme-1 alpha (IRE1a) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IRE1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2309519-81-9
  • Formula Weight
    446.41
  • Molecular Formula
    C24H29Cl2N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1C[C@@]2(CN(C(NCC3=CC=C(C)C=C3)=O)CCC2)CC1)C4=CC(Cl)=C(Cl)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nestor O. Concha, et al. Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1αEndoribonuclease Activity. Molecular Pharmacology December 2015, 88 (6) 1011-1023.
molnova catalog
related products
  • MRGPRX1 agonist 1

    MRGPRX1 agonist 1 is a highly potent MRGPRX1 (Mas-related G-protein-coupled receptor X1)agonist(EC50 of 50 nM).

  • Picrinine

    Picrinine is an akuammiline alkaloid extracted from the leaves of Alstonia scholaris. It exhibits anti-inflammatory activity by inhibiting 5-lipoxygenase.

  • WJ460

    WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells.